Monday - November 16, 2026
Boehringer Ingelheim Expands 'Detect SOS' Mission Globally to Address UACR Testing Gap That Leaves Millions Vulnerable to Undetected Heart, Kidney Risks
September 22, 2026
INGELHEIM AM RHEIN, Germany, Sept. 22 (TNSrep) -- Boehringer Ingelheim, a pharmaceutical company, issued the following news release:

* * *

Boehringer Ingelheim expands 'Detect the SOS' mission globally to address the uACR testing gap that leaves millions vulnerable to undetected heart and kidney risks

Ingelheim, Germany, Mon, 21/09/2026

* Millions of adults with hypertension, type 2 diabetes, or both remain vulnerable to serious hidd . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products